Insmed (INSM) Accumulated Expenses (2010 - 2024)

Insmed has reported Accumulated Expenses for 15 years, with the latest figure at $248.7 million in Q3 2024.

• On a quarterly basis, Accumulated Expenses rose 32.43% year-over-year to $248.7 million in Q3 2024; TTM through Sep 2024 was $248.7 million, a 32.43% increase from a year earlier, with the FY2023 full-year figure at $215.0 million, up 18.05% from the prior year.
• Accumulated Expenses was $248.7 million for Q3 2024 at Insmed, down from $290.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $290.8 million in Q2 2024, with the low at $31.9 million in Q2 2020.
• Average Accumulated Expenses over 5 years is $123.5 million, with a median of $125.0 million recorded in 2021.
• The sharpest annual moves came in 2020 and 2023: Accumulated Expenses tumbled 35.33% in 2020, then surged 236.32% in 2023.
• Over 5 years, Accumulated Expenses stood at $37.8 million in 2020, then jumped by 230.71% to $125.0 million in 2021, then soared by 45.66% to $182.1 million in 2022, then climbed by 18.05% to $215.0 million in 2023, then increased by 15.67% to $248.7 million in 2024.
• The last three Accumulated Expenses figures came in at $248.7 million (Q3 2024), $290.8 million (Q2 2024), and $189.4 million (Q1 2024), per Business Quant data.